• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心律失常药物致心律失常反应的临床类型。

Clinical types of proarrhythmic response to antiarrhythmic drugs.

作者信息

Bigger J T, Sahar D I

出版信息

Am J Cardiol. 1987 Apr 30;59(11):2E-9E. doi: 10.1016/0002-9149(87)90195-0.

DOI:10.1016/0002-9149(87)90195-0
PMID:3554950
Abstract

The problem of drug-induced or drug-aggravated cardiac arrhythmias has been recognized for many years. Digitalis glycosides and class I, II, III, or IV antiarrhythmic drugs can cause severe sinus node dysfunction or atrioventricular block. Digitalis can cause a variety of supraventricular arrhythmias; atrial tachycardia with block and nonparoxysmal atrioventricular junctional tachycardia are the most characteristic. Recognition that class IA and class III antiarrhythmic drugs can aggravate arrhythmias or cause new arrhythmias in patients being treated for potentially malignant or malignant ventricular arrhythmias has intensified the interest in proarrhythmia in recent years. Several characteristic types of proarrhythmic response have been described. Torsades de pointes (multiform) ventricular tachycardia (VT) accompanied by prolongation of the QT interval can be caused by class IA and class III antiarrhythmic drugs as well as other drugs that bind to the membrane sodium channels of ventricular cells, for example, tricyclic antidepressants. Uniform VT in patients with malignant ventricular arrhythmias and poor left ventricular function is a characteristic proarrhythmic response to class IC antiarrhythmic drugs. Bidirectional VT or accelerated idioventricular rhythm are characteristic of digitalis toxicity. More difficult to establish as proarrhythmic responses are increased frequency of ventricular premature depolarizations and increased ease of inducing VT with programmed ventricular stimulation.

摘要

药物诱发或加重的心律失常问题已被认识多年。洋地黄苷类以及I类、II类、III类或IV类抗心律失常药物可导致严重的窦房结功能障碍或房室传导阻滞。洋地黄可引起多种室上性心律失常;伴有阻滞的房性心动过速和非阵发性房室交界性心动过速最为典型。近年来,认识到IA类和III类抗心律失常药物可使正在接受潜在恶性或恶性室性心律失常治疗的患者的心律失常加重或引发新的心律失常,这使得人们对致心律失常作用的关注度提高。已经描述了几种特征性的致心律失常反应类型。IA类和III类抗心律失常药物以及其他与心室细胞的膜钠通道结合的药物(例如三环类抗抑郁药)可导致伴有QT间期延长的尖端扭转型(多形性)室性心动过速(VT)。恶性室性心律失常且左心室功能较差的患者出现的单形性VT是对IC类抗心律失常药物的特征性致心律失常反应。双向VT或加速性室性自主心律是洋地黄毒性的特征。更难以确定为致心律失常反应的是室性早搏去极化频率增加以及通过程控心室刺激诱发VT的易感性增加。

相似文献

1
Clinical types of proarrhythmic response to antiarrhythmic drugs.抗心律失常药物致心律失常反应的临床类型。
Am J Cardiol. 1987 Apr 30;59(11):2E-9E. doi: 10.1016/0002-9149(87)90195-0.
2
Proarrhythmic effects of antiarrhythmic drugs.
Med J Aust. 1990 Jul 2;153(1):37-47. doi: 10.5694/j.1326-5377.1990.tb125462.x.
3
[The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].[抗心律失常药物的致心律失常作用——理论与临床方面]
Z Kardiol. 1992;81 Suppl 4:139-43.
4
Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.IC类抗心律失常药物治疗并存的室上性和室性心动过速的疗效与安全性。
Am J Cardiol. 1988 Aug 25;62(6):44D-55D. doi: 10.1016/0002-9149(88)90507-3.
5
Proarrhythmic responses during electrophysiologic testing.电生理检查期间的致心律失常反应。
Am J Cardiol. 1987 Apr 30;59(11):45E-48E. doi: 10.1016/0002-9149(87)90201-3.
6
Proarrhythmic effects of antiarrhythmic drugs assessed by electrophysiologic study in recurrent sustained ventricular tachycardia.
Jpn Circ J. 1991 Feb;55(2):133-41. doi: 10.1253/jcj.55.133.
7
[Proarrhythmic effects of anti-arrhythmia agents].[抗心律失常药物的促心律失常作用]
Rev Med Interne. 1995;16(8):602-7. doi: 10.1016/0248-8663(96)80759-4.
8
[Antiarrhythmic therapy in patients with heart failure].心力衰竭患者的抗心律失常治疗
Ther Umsch. 2000 May;57(5):324-32. doi: 10.1024/0040-5930.57.5.324.
9
[The pro-arrhythmic effects of anti-arrhythmia agents].[抗心律失常药物的促心律失常作用]
Z Kardiol. 1994;83 Suppl 5:75-85.
10
Proarrhythmic actions of antiarrhythmic drugs: a review.
Aust N Z J Med. 1990 Jun;20(3):275-82. doi: 10.1111/j.1445-5994.1990.tb01039.x.

引用本文的文献

1
Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC.抗心律失常药物实用手册:欧洲心脏病学会(ESC)欧洲心律协会临床共识声明
Europace. 2025 Mar 30. doi: 10.1093/europace/euaf076.
2
Analysis of Personalized Cardiovascular Drug Therapy: From Monitoring Technologies to Data Integration and Future Perspectives.个性化心血管药物治疗分析:从监测技术到数据整合及未来展望
Biosensors (Basel). 2025 Mar 17;15(3):191. doi: 10.3390/bios15030191.
3
Effects of SZV-2649, a new multiple ion channel inhibitor mexiletine analogue.
新型多离子通道抑制剂美西律类似物 SZV-2649 的作用。
Sci Rep. 2024 Oct 5;14(1):23188. doi: 10.1038/s41598-024-73576-5.
4
Ivabradine in the treatment of non-paroxysmal junctional tachycardia with interference atrioventricular dissociation: A case report.伊伐布雷定治疗伴干扰性房室分离的非阵发性交界性心动过速 1 例报告。
Ann Noninvasive Electrocardiol. 2023 Jul;28(4):e13064. doi: 10.1111/anec.13064. Epub 2023 May 8.
5
Genetic Complexity of Sinoatrial Node Dysfunction.窦房结功能障碍的遗传复杂性
Front Genet. 2021 Apr 1;12:654925. doi: 10.3389/fgene.2021.654925. eCollection 2021.
6
Adverse effects of class I antiarrhythmic drugs.I类抗心律失常药物的不良反应。
Drug Saf. 1997 Jul;17(1):8-36. doi: 10.2165/00002018-199717010-00002.
7
Drug effects on the electrocardiogram. A review of their clinical importance.药物对心电图的影响。对其临床重要性的综述。
Drugs. 1993 Aug;46(2):219-48. doi: 10.2165/00003495-199346020-00002.
8
The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations.心房颤动的治疗。药物治疗、电学方法及治疗考量的评估。
Drugs. 1994 Sep;48(3):345-71. doi: 10.2165/00003495-199448030-00003.
9
Changes in the distribution of ventricular ectopic beats in long-term electrocardiograms.长期心电图中心室性早搏分布的变化。
Med Biol Eng Comput. 1990 Sep;28(5):423-30. doi: 10.1007/BF02441965.
10
Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.抗心律失常药物分类。对其历史、现状及临床相关性的批判性评价。
Drugs. 1991 May;41(5):672-701. doi: 10.2165/00003495-199141050-00002.